These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 18188033

  • 21. [Bile composition and antibiotic excretion. Observations with T-drainage].
    Rosenthal RJ, Steigerwald SD, Bockhorn H.
    Z Gesamte Inn Med; 1993 Jan; 48(1):18-22. PubMed ID: 8095119
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The pharmacokinetics of the biliary excretion of ciprofloxacin.
    Ball CS, Manson JM, Reid F, Tweedle DE.
    HPB Surg; 1989 Nov; 1(4):319-26; discussion 326-7. PubMed ID: 2487071
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Ciprofloxacin use in critically ill patients: pharmacokinetic and pharmacodynamic approaches.
    Conil JM, Georges B, de Lussy A, Khachman D, Seguin T, Ruiz S, Cougot P, Fourcade O, Houin G, Saivin S.
    Int J Antimicrob Agents; 2008 Dec; 32(6):505-10. PubMed ID: 18768301
    [Abstract] [Full Text] [Related]

  • 26. Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis.
    Gous A, Lipman J, Scribante J, Tshukutsoane S, Hon H, Pinder M, Mathivha R, Verhoef L, Stass H.
    Int J Antimicrob Agents; 2005 Jul; 26(1):50-5. PubMed ID: 15955670
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Can biliary-cyst communication be predicted before surgery for hepatic hydatid disease: does size matter?
    Kilic M, Yoldas O, Koc M, Keskek M, Karakose N, Ertan T, Gocmen E, Tez M.
    Am J Surg; 2008 Nov; 196(5):732-5. PubMed ID: 18513700
    [Abstract] [Full Text] [Related]

  • 29. [Diffusion of ciprofloxacin into bronchial secretions in mechanically ventilated patients].
    Saux P, Martin C, Portet C, Bruguerolle B, Papazian L, Mallet MN, Gouin F.
    Pathol Biol (Paris); 1991 May; 39(5):515-9. PubMed ID: 1881686
    [Abstract] [Full Text] [Related]

  • 30. Plastic versus self-expanding metallic stents for malignant hilar biliary obstruction: a prospective multicenter observational cohort study.
    Perdue DG, Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Overby CS, Ryan ME, Bochna GS, Snady HW, Moore JP, ERCP Outcome Study ERCOST Group.
    J Clin Gastroenterol; 2008 Oct; 42(9):1040-6. PubMed ID: 18719507
    [Abstract] [Full Text] [Related]

  • 31. A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost.
    Yoon WJ, Ryu JK, Yang KY, Paik WH, Lee JK, Woo SM, Park JK, Kim YT, Yoon YB.
    Gastrointest Endosc; 2009 Aug; 70(2):284-9. PubMed ID: 19539921
    [Abstract] [Full Text] [Related]

  • 32. (1)H and (31)P NMR studies indicate reduced bile constituents in patients with biliary obstruction and infection.
    Bala L, Tripathi P, Bhatt G, Das K, Roy R, Choudhuri G, Khetrapal CL.
    NMR Biomed; 2009 Feb; 22(2):220-8. PubMed ID: 18837066
    [Abstract] [Full Text] [Related]

  • 33. Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography.
    Ratanachu-ek T, Prajanphanit P, Leelawat K, Chantawibul S, Panpimanmas S, Subwongcharoen S, Wannaprasert J.
    World J Gastroenterol; 2007 Jan 14; 13(2):276-9. PubMed ID: 17226908
    [Abstract] [Full Text] [Related]

  • 34. Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant.
    McPherson C, Gal P, Ransom JL.
    Ann Pharmacother; 2008 Jul 14; 42(7):1134-8. PubMed ID: 18577764
    [Abstract] [Full Text] [Related]

  • 35. The intravitreal penetration of orally administered ciprofloxacin in humans.
    Keren G, Alhalel A, Bartov E, Kitzes-Cohen R, Rubinstein E, Segev S, Treister G.
    Invest Ophthalmol Vis Sci; 1991 Jul 14; 32(8):2388-92. PubMed ID: 2071350
    [Abstract] [Full Text] [Related]

  • 36. Increased melibiose/rhamnose ratio in bile of rats with acute cholestasis.
    Tomsik P, Sispera L, Rezacova M, Niang M, Stoklasova A, Cerman J, Knizek J, Brcakova E, Cermanova J, Micuda S.
    J Gastroenterol Hepatol; 2008 Dec 14; 23(12):1934-40. PubMed ID: 18717760
    [Abstract] [Full Text] [Related]

  • 37. Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective.
    Pea F, Poz D, Viale P, Pavan F, Furlanut M.
    J Antimicrob Chemother; 2006 Aug 14; 58(2):380-6. PubMed ID: 16735422
    [Abstract] [Full Text] [Related]

  • 38. Penetration of ciprofloxacin and its desethylenemetabolite into skin in humans after a single oral dose of the parent drug assessed by cutaneous microdialysis.
    Bielecka-Grzela S, Klimowicz A.
    J Clin Pharm Ther; 2005 Aug 14; 30(4):383-90. PubMed ID: 15985052
    [Abstract] [Full Text] [Related]

  • 39. Significance of serum delta-bilirubin in patients with obstructive jaundice.
    Kozaki N, Shimizu S, Higashijima H, Kuroki S, Yamashita H, Yamaguchi K, Chijiiwa K, Tanaka M.
    J Surg Res; 1998 Sep 14; 79(1):61-5. PubMed ID: 9735241
    [Abstract] [Full Text] [Related]

  • 40. Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract.
    van den Hazel SJ, de Vries XH, Speelman P, Dankert J, Tytgat GN, Huibregtse K, van Leeuwen DJ.
    Antimicrob Agents Chemother; 1996 Nov 14; 40(11):2658-60. PubMed ID: 8913485
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.